Christine Henderson Dougan

This inventor holds 11 USPTO granted patents, plus 5 CIPO patents and 5 EPO patents. Top assignees: Ocera Therapeutics, Inc., Amalive Limited. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christine Henderson Dougan. Retrieved from https://idiyas.com/inventor/christine-henderson-dougan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 90.9

CIPO Patents = 5 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 6.0

ph-index = 8

Forward Citations = 211(Granted Patents)

Company Filing History:

10 out of 27

Ocera Therapeutics, Inc.

Years Active: 2012-2026

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12516015 - L-ornithine phenyl acetate and methods of making thereof (2026-01-06),

2. 11161802 - L-ornithine phenyl acetate and methods of making thereof (2021-11-02),

3. 10550069 - L-ornithine phenyl acetate and methods of making thereof (2020-02-04),

4. 10173964 - L-ornithine phenyl acetate and methods of making thereof (2019-01-08),

5. 9604909 - L-ornithine phenyl acetate and methods of making thereof (2017-03-28),

6. 9260379 - Methods of making L-ornithine phenyl acetate (2016-02-16),

7. 9034925 - L-ornithine phenyl acetate and methods of making thereof (2015-05-19),

8. 8946473 - Methods of making L-ornithine phenyl acetate (2015-02-03),

9. 8785498 - L-ornithine phenyl acetate and methods of making thereof (2014-07-22),

10. 8492439 - L-ornithine phenyl acetate and methods of making thereof (2013-07-23),

11. 8173706 - L-ornithine phenyl acetate and methods of making thereof (2012-05-08),

Title: Biography of Christine Henderson Dougan

Introduction: Christine Henderson Dougan is an accomplished inventor based in Glasgow, GB, known for her significant contributions to the field of pharmaceuticals. With a total of 10 patents to her name, she has made remarkable advancements in the treatment of liver disorders.

Latest Patents: One of her latest patents includes L-ornithine phenyl acetate and methods of making thereof. This invention discloses various forms of L-ornithine phenyl acetate, including crystalline forms that may be used for treating subjects with liver disorders, such as hepatic encephalopathy. The patent outlines formulations and methods for administering this compound effectively.

Career Highlights: Christine is currently associated with Ocera Therapeutics, Inc., where she continues to innovate and develop new therapeutic solutions. Her work has been pivotal in advancing medical treatments and improving patient outcomes.

Collaborations: Throughout her career, Christine has collaborated with notable professionals in her field, including Keith Anderson and Jim Behling. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion: Christine Henderson Dougan's contributions to the field of pharmaceuticals, particularly in the treatment of liver disorders, underscore her role as a leading inventor. Her ongoing work and innovative spirit continue to inspire advancements in medical science.

Profile summary based on public USPTO records.